title: Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey.
authors.affiliation: Diabetes Research Institute, Mills-Peninsula Health Services, San Mateo, CA, USA dklonoff@diabetestechnology.org.
authors.forename: David
authors.initials: D
authors.lastname: Klonoff
authors.affiliation: Diabetes Research Institute, Mills-Peninsula Health Services, San Mateo, CA, USA.
authors.forename: Irina
authors.initials: I
authors.lastname: Nayberg
authors.affiliation: Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Erbstein
authors.affiliation: Sanofi, Paris, France.
authors.forename: Anna
authors.initials: A
authors.lastname: Cali
authors.affiliation: Sanofi, Paris, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Brulle-Wohlhueter
authors.affiliation: Diabetes Klinik Bad Mergentheim, Bad Mergentheim, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Haak
mesh_terms: D002755:Choice Behavior; D004209:Disposable Equipment; D016503:Drug Delivery Systems; D004867:Equipment Design; D005060:Europe; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous / Q000295:instrumentation*; D007328:Insulin / Q000008:administration & dosage*; D007564:Japan; D017060:Patient Satisfaction; D011795:Surveys and Questionnaires; D013594:Syringes; D014481:United States
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Gla-300 SoloSTAR; insulin pen; interview-based survey; usability